Abstract
Sulphasalazine-induced Raynaud's phenomenon is reported in a patient who showed no other features of a drug-induced lupus syndrome. The vascular disturbance disappeared when the drug was withdrawn on 3 occasions. A simple technique for assessing the circulatory abnormality in Raynaud's phenomenon is described.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALARCON SEGOVIA D., HERSKOVIC T., DEARING W. H., BARTHOLOMEW L. G., CAIN J. C., SHORTER R. G. LUPUS ERYTHEMATOSUS CELL PHENOMENON IN PATIENTS WITH CHRONIC ULCERATIVE COLITIS. Gut. 1965 Feb;6:39–47. doi: 10.1136/gut.6.1.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Alarcón-Segovia D. Drug-induced lupus syndromes. Mayo Clin Proc. 1969 Sep;44(9):664–681. [PubMed] [Google Scholar]
- Das K. M., Eastwood M. A., McManus J. P., Sircus W. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. N Engl J Med. 1973 Sep 6;289(10):491–495. doi: 10.1056/NEJM197309062891001. [DOI] [PubMed] [Google Scholar]
- Griffiths I. D., Kane S. P. Sulphasalazine-induced lupus syndrome in ulcerative colitis. Br Med J. 1977 Nov 5;2(6096):1188–1189. doi: 10.1136/bmj.2.6096.1188. [DOI] [PMC free article] [PubMed] [Google Scholar]